Advertisement
Advertisement
RMD
ResMed Inc.
271.85
USDSponsored
+4.80
+1.80%
Feb 06, 16:00 UTC -5
Closed
After-Market
271.65
-0.20
-0.07%
RMD Earnings Reports
Positive Surprise Ratio
RMD beat 27 of 40 last estimates.
68%
Next Report
Date of Next Report
Apr 21, 2026
Estimate for Q3 26 (Revenue/ EPS)
$1.44B
/$2.83
Implied change from Q2 26 (Revenue/ EPS)
+1.00%
/+0.71%
Implied change from Q3 25 (Revenue/ EPS)
+11.25%
/+19.41%
ResMed Inc. earnings per share and revenue
On Jan 29, 2026, RMD reported earnings of 2.81 USD per share (EPS) for Q2 26, beating the estimate of 2.75 USD, resulting in a 2.15% surprise. Revenue reached 1.42 billion, compared to an expected 1.41 billion, with a 0.89% difference. The market reacted with a +0.27% price change (close before vs. close after earnings).
Looking ahead to Q3 26, 17 analysts forecast an EPS of 2.83 USD, with revenue projected to reach 1.44 billion USD, implying an increase of 0.71% EPS, and increase of 1.00% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Stryker Corporation
Report Date
Jan 29, 2026 For Q4 25
Estimate
$4.43
Actual
$4.47
Surprise
+0.69%
Boston Scientific Corp.
Report Date
Feb 04, 2026 For Q4 25
Estimate
$0.78
Actual
$0.80
Surprise
+1.61%
GE HealthCare Technologies Inc. Common Stock
Report Date
Feb 04, 2026 For Q4 25
Estimate
$1.42
Actual
$1.44
Surprise
+0.96%
Envista Holdings Corporation Common stock, $0.01 par value per share
Report Date
Feb 05, 2026 For Q4 25
Estimate
$0.32
Actual
$0.38
Surprise
+15.43%
Prestige Consumer Healthcare Inc.
Report Date
Feb 05, 2026 For Q3 26
Estimate
$1.15
Actual
$1.13
Surprise
-1.36%
Haemonetics Corporation
Report Date
Feb 05, 2026 For Q3 26
Estimate
$1.26
Actual
$1.31
Surprise
+3.75%
Phibro Animal Health Corporation Class A
Report Date
Feb 04, 2026 For Q2 26
Estimate
$0.68
Actual
$0.87
Surprise
+27.30%
Canopy Growth Corporation Common Shares
Report Date
Feb 06, 2026 For Q3 26
Estimate
-$0.04
Actual
-$0.13
Surprise
-198.00%
Aurora Cannabis Inc. Common Shares
Report Date
Feb 04, 2026 For Q3 26
Estimate
$0.21
Actual
$0.12
Surprise
-42.72%
High Tide Inc. Common Shares
Report Date
Jan 29, 2026 For Q4 25
Estimate
$0.00
Actual
-$0.56
Surprise
0.00%
FAQ
What were ResMed Inc.'s earnings and revenue for the latest quarter Q2 2026?
For Q2 2026, ResMed Inc. reported EPS of $2.81, beating estimates by 2.15%, and revenue of $1.42B, 0.89% above expectations.
How did the market react to ResMed Inc.'s Q2 2026 earnings?
The stock price moved up 0.27%, changed from $257.61 before the earnings release to $258.31 the day after.
When is ResMed Inc. expected to report next?
The next earning report is scheduled for Apr 21, 2026.
What are the forecasts for ResMed Inc.'s next earnings report?
Based on 17
analysts, ResMed Inc. is expected to report EPS of $2.83 and revenue of $1.44B for Q3 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement